【引用本文】王 权，李 爽. 免疫治疗时代Ⅳ期胃癌转化治疗方案选择[J]. 中国实用外科杂志,2024,44(10):1129-1133.  摘要 ...

The Phase 3 program is expected to enroll approximately 5,000 subjects across the four trials. The safety and efficacy of pemvidutide doses of 1.2 mg, 1.8 mg, and 2.4 mg will be evaluated with the ...

IMNN-001 immunotherapy plus standard-of-care chemotherapy resulted in 35% improvement in overall survival and 25% improvement in progression-free ...

Ionis has announced the design for a Phase III trial of ION582, a treatment for Angelman syndrome (AS), following discussions with the FDA.

接种癌症疫苗的本质在于激活人体免疫系统，使之精准识别并有效攻击癌细胞。该疗法的首要目标是控制肿瘤的生长，预防其复发或转移，并强化免疫系统识别和清除癌细胞的能力。癌症疫苗的作用机理在于诱发针对特定肿瘤相关抗原（TAA，即由癌细胞表达的独特蛋白质）的免疫 ...

Phase III trials are conducted to provide stronger evidence of the effectiveness and safety of a therapeutic intervention and typically form a key part of applications to regulatory authorities to ...

Here the authors conduct a phase II clinical trial evaluating the efficacy and safety of combining apatinib (VEGFR2 inhibitor) and HAIC (oxaliplatin plus raltitrexed) in patients with advanced HCC ...

Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat ...

The FDA recently approved a phase 2 clinical trial to investigate the efficacy of leronlimab in patients with relapsed or ...

ZUG, Switzerland--(BUSINESS WIRE)--Galderma today announced new phase III data from the READY-4 clinical trial, demonstrating the long-term safety of RelabotulinumtoxinA (Relfydess ™) for frown ...

In an interview with David Hutton of Ophthalmology Times, Ash Abbey, MD, discusses the Phase 3 LUGANO trial for EYP-1901 in treating wet age-related macular degeneration. Abbey discusses the trial’s ...